The estimated Net Worth of Lisa D Earnhardt is at least $33.3 Million dollars as of 7 May 2024. Ms. Earnhardt owns over 22,852 units of Abbott Laboratories stock worth over $7,166,469 and over the last 10 years she sold ABT stock worth over $18,669,619. In addition, she makes $7,478,840 as Executive Vice President - Medical Devices at Abbott Laboratories.
Lisa has made over 49 trades of the Abbott Laboratories stock since 2015, according to the Form 4 filled with the SEC. Most recently she sold 22,852 units of ABT stock worth $2,428,025 on 7 May 2024.
The largest trade she's ever made was exercising 35,000 units of Abbott Laboratories stock on 20 December 2018 worth over $42,000. On average, Lisa trades about 11,359 units every 50 days since 2015. As of 7 May 2024 she still owns at least 61,462 units of Abbott Laboratories stock.
You can see the complete history of Ms. Earnhardt stock trades at the bottom of the page.
Lisa D. Earnhardt serves as Executive Vice President - Medical Devices of the Company. She serves from 2008 to 2019 — President, CEO, and Director, Intersect ENT (a medical technology company focused on developing treatments for ear, nose and throat conditions).
As the Executive Vice President - Medical Devices of Abbott Laboratories, the total compensation of Lisa Earnhardt at Abbott Laboratories is $7,478,840. There are 2 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $27,802,800.
Lisa Earnhardt is 50, she's been the Executive Vice President - Medical Devices of Abbott Laboratories since 2019. There are 35 older and 7 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Lisa's mailing address filed with the SEC is 100 ABBOTT PARK ROAD, , ABBOTT PARK, IL, 60064.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez, and Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: